1252633-65-0

Upstream product

• 1252633-41-2 (2S,4R)-tert-butyl 4-(2-chloro-4-fluorophenylsulfonyl)-2-(1-cyanocyclopropylcarbamoyl)pyrrolidine-1-carboxylate 
• 1252633-25-2 (2S,4S)-1-tert-butyl 2-methyl 4-(3-nitrophenylsulfonyloxy)pyrrolidine-1,2-dicarboxylate 
• 74844-91-0 (2S,4S)-N-tert-butoxycarbonyl-4-hydroxyproline methyl ester 
• 1252632-24-8 tert-butyl (2S,4R)-4-[(2-chlorophenyl)sulfonyl]-2-{[(1-cyanocyclopropyl)amino]carbonyl}pyrrolidine-1-carboxylate 
• 1252632-10-2 (2S,4R)-1-tert-butyl 2-methyl 4-(2-chlorophenylsulfonyl)pyrrolidine-1,2-dicarboxylate 
• 1252632-04-4 1-tert-butyl 2-methyl (2S,4R)-4-[(2-chlorophenyl)sulfanyl]pyrrolidine-1,2-dicarboxylate 

Relevant academic research and scientific papers

NOVEL PYRROLIDINE DERIVATIVES

The invention relates to a compound of formula (I) wherein A1 to A3 and R1 to R3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.

NOVEL PYRROLIDINE DERIVATIVES

The invention relates to a compound of formula (I) wherein A1 to A3 and R1 to R3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.

NOVEL PROLINE DERIVATIVES

The invention relates to a compound of formula (I) wherein A, R1-R6 are as defined in the description and in the claims. The compound of formula (I) can be used as a medicament.